J. Brad Shotwell
AbbVie (United States)(US)The University of Texas Medical Branch at Galveston(US)
Publications by Year
Research Areas
Metabolism, Diabetes, and Cancer, Cancer, Hypoxia, and Metabolism, PI3K/AKT/mTOR signaling in cancer, DNA Repair Mechanisms, Hepatitis C virus research
Most-Cited Works
- → Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas(2020)212 cited
- → GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers(2009)98 cited
- → The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors(2015)80 cited
- → Structure and Energetics of the Samarium Diiodide−HMPA Complex in Tetrahydrofuran(1999)71 cited
- → Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB(2016)71 cited
- → Discovery of Selective Small Molecule Type III Phosphatidylinositol 4-Kinase Alpha (PI4KIIIα) Inhibitors as Anti Hepatitis C (HCV) Agents(2013)67 cited